1.—(1) The bodies specified in column 1 of Table 1, being bodies appearing to the Secretary of State to represent UK producers, are prescribed for the purposes of section 264B(1)(k) of the 2006 Act.
(2) The purpose for which a body specified in column 1 of Table 1 may use confidential or commercially sensitive information disclosed to it under section 264B(1) of the 2006 Act is the purpose prescribed in the corresponding entry in column 2 of that Table.
Table 1
| Column 1 – Bodies | Column 2 – The purpose for which information disclosed under section 264B(1) of the 2006 Act may be used |
|---|---|
Association of British Healthcare Industries; Association of Pharmaceutical Specials Manufacturers; British Association of European Pharmaceutical Distributors; British Generic Manufacturers Association; British Healthcare Trades Association; British In Vitro Diagnostics Association; Healthcare Distribution Association; NHS Pharmacy Production Committee; NHS Pharmaceutical Quality Assurance; Proprietary Association of Great Britain; Surgical Dressings Manufacturers Association Committee; Urology Trade Association. | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(a) to (l). |
Association of Independent Multiple Pharmacies; Company Chemists’ Association; National Pharmacy Association. | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(a) to (k). |
BioIndustry Association; Ethical Medicines Industry Group. | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(c), (e), (g), (i), (l) and (m). |
| Association of the British Pharmaceutical Industry | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(c), (e), (g), (i) and (k) to (m). |
British Medical Association; Dispensing Doctor’s Association. | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(a), (c), (d), (f), (g) and (i) to (k). |
| Pharmaceutical Services Negotiating Committee | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(b) and (c). |